• SENSEX 76,132.81
    -382.62 (--0.50%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Syrma SGS Tech.
    1,644.85 1,543.40(%)
  • IFCI
    107.30 107.45(%)
  • PC Jeweller
    14.07 15.38(%)
  • Swiggy
    280.45 473.00(%)
  • ICICI Bank
    1,433.95 1,479.90(%)
  • Milky Mist Dairy
    277.80 268.75(%)
  • MV Electrosystems
    841.00 780.50(%)
  • Kotak Mah. Bank
    421.00 345.40(%)
  • ASM Technologies
    6,275.95 5,440.00(%)
  • Bharti Airtel
    1,855.10 2,174.70(%)
  • Ather Energy
    1,617.95 1,741.90(%)
  • Pidilite Inds.
    1,585.00 1,259.45(%)
  • Netweb Technol.
    5,138.35 2,514.75(%)
  • Lalithaa Jewel
    326.75 308.55(%)
  • Cummins India
    4,987.55 3,802.55(%)
  • Gland Pharma
    3,041.95 3,039.00(%)
  • HDFC Bank
    707.25 698.50(%)
  • SBI
    1,001.00 803.60(%)
  • Multi Comm. Exc.
    3,374.15 3,479.80(%)
  • Aditya Birla Cap
    408.75 430.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Remus Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 78788.0
  • ISIN : INE0O5T01011
890.05 -4 (-0.45%)
  • As on 07 Sep 2026 (EOD)

  • Today’s Low

    886.05

  • Today’s High

    906.00

  • Open

    886.05

  • Perv Close

    894.10

  • 52W Low

    580.00

  • 52W High

    987.50

Key Indicators

  • P/E(TTM)

    42.44

  • Mar.Cap (₹Cr.)

    1,048.83

  • Div & Yield %

    0.06

  • Book Value(₹)

    276.40

  • Debt-Equity Ratio

    -0.45

  • AGM Date

    04-Sep-2026

  • EPS

    20.97

  • P/E Ratio

    42.44

Financials Ratios

  • Debt-Equity Ratio

    0.09

  • Mar.Cap (₹Cr.)

    1,048.83

  • RONW (%)

    15.40

  • ROCE (%)

    17.79

Score Board

  • Equity (₹ in Cr.)

    11.78

  • BV (₹)

    276.40

  • Sales( ₹ in Cr.)

    93.99

  • NP (in Cr.)

    24.71

  • NP Var(%)

    25.0

  • Div%

    5.0

  • CPS (₹)

    23.30

  • EPS (₹)

    21.00

  • Traded Value (₹ in Lakhs)

    1,048.83

  • 52 Week High

    987.50

  • 52 Week Low

    580.00

  • Price BSE

    0.0

  • Price NSE

    890.00

  • Market Capital( in Cr.)

    1,048.83

  • P/C Ratio

    38.20

  • P/E Ratio

    42.40

  • Price Vs.BV

    21.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 79.16 63.94 45.03 24.72 18.42 11.92
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 79.16 63.94 45.03 24.72 18.42 11.92
Other Income 2.91 2.81 1.58 0.72 0.81 0.85
Stock Adjustments 0.23 1.53 -1.30 0.44 0.71 0.40
Total Income 82.30 68.28 45.31 25.88 19.94 13.17
EXPENDITURE :            
Raw Materials 35.27 29.21 20.14 12.71 12.21 7.44
Power and Fuel Cost 0.04 0.00 0.00 0.00 0.00 0.01
Employee Cost 9.17 6.51 5.47 3.42 2.95 2.86
Other Manufacturing Expenses 3.73 4.05 4.57 2.02 0.00 0.26
Selling and Administration Expenses 4.82 4.45 2.98 2.70 0.00 1.37
Miscellaneous Expenses 0.38 0.25 0.02 0.17 3.17 0.00
Employee Benefit Expenses 9.17 6.51 5.47 3.42 2.95 2.86
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 53.41 44.47 33.18 21.02 18.33 11.93
Operating Profit 28.89 23.81 12.12 4.86 1.61 1.24
Interest 0.38 0.34 0.23 0.09 0.03 0.04
Gross Profit 28.51 23.47 11.89 4.77 1.58 1.20
Depreciation 1.87 1.12 0.48 0.15 0.18 0.11
Profit Before Tax 26.64 22.35 11.41 4.62 1.40 1.09
Current Tax 6.67 6.41 3.00 1.19 0.37 0.31
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.07 -0.68 -0.09 -0.01 -0.02 -0.02
Reported Net Profit 19.90 16.62 8.50 3.43 1.06 0.81
Extraordinary Items 0.15 0.00 0.00 0.01 0.08 0.00
Adjusted Net Profit 19.75 16.62 8.50 3.42 0.98 0.81
Adjustment below Net Profit -4.43 0.00 -0.20 -0.99 0.00 0.00
P & L Balance brought forward 29.81 13.78 5.58 3.13 2.07 1.20
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.18 0.59 0.00 0.00 0.00 0.00
P & L Balance carried down 44.10 29.81 13.89 5.58 3.13 2.01
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 15.00 60.00 20.00 0.00 0.00 0.00
Dividend Per Share(Rs) 1.50 6.00 2.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 33.79 113.06 78.37 34.34 1,059.50 811.60
Earnings Per Share(Adj)-Unit Curr 16.90 14.13 - - - -
Book Value 411.24 1,044.56 176.36 65.78 3,143.70 2,020.30
Book Value(Adj)-Unit Curr 205.62 130.57 - - - -

Shareholding Pattern

  • Promoter Group

    70.95%

  • Public Share Holding

    29.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 108,500 0.92 108,500 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 8,252,700 70.03 8,252,700 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 8,361,200 70.95 8,361,200 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 622,600 5.28 622,600 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 97,800 0.83 97,800 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 720,400 6.11 720,400 5
2] Non Institution
Bodies Corporate 129,400 1.10 129,400 31
Clearing Members 1,000 0.01 1,000 1
Directors of their Relatives 16,000 0.14 16,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 25,400 0.22 25,400 53
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 307,300 2.61 307,300 140
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 814,600 6.91 814,600 15
Individuals holding nominal share capital up to Rs. 1 lakh 1,366,000 11.59 1,366,000 1,745
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 1,600 0.01 1,600 1
Sub Total 2,702,400 22.93 2,702,400 1,993
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,784,000 100.00 11,784,000 2,009

Company Background

Remus Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Remus Pharmaceuticals Ltd
  • BSE Code : 78788.0
  • ISIN : INE0O5T01011

  • Incorporation Year

    2015

  • Registered Office

    1101 to 1103 South Tower One42
    B/H Ashok Vatika Amblibopal Rd, Ahmedabad,
    Gujarat-380054

  • Telephone

    91-079-29999857

  • FAX

  • Chairman

    SWAPNIL JATINBHAI SHAH

  • Managing Director

    ARPIT DEEPAKKUMAR SHAH

  • Company Secretary

    Deval Patel

  • Auditor

    Pankaj R Shah & Associates

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Remus Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Remus Pharma. 890.05 82.07 79.16 42.44 13.33
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 393.10 354.33 41.34 15.94
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77